Recall archive / FDA drug enforcement
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7 — FDA record D-0397-2026
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Dec 15, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
- Reason
- Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
- Classification
- Class I
- Recalling firm
- StuffbyNainax
- Quantity
- 4
- Agency-reported status
- Ongoing
- Source record identifier
- D-0397-2026
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | All codes; Exp 12/31/2029 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Product was distributed to 4 customers in the US.
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Report date
- Mar 11, 2026
- Recall initiation date
- Dec 15, 2025
- Center classification date
- Mar 18, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.